top of page

18093149037

Hybrid indoor/outdoor year-round cultivator with hand-picked genetics producing high quality flower/biomass at industry-low prices

Licence(s) Held:

Medicinal Cannabis Licence

18093149037

Seeking strategic investment of $3.5 million AUD

  • Leading Australian medical cannabis cultivator, poised to be a major organic, outdoor-indoor hybrid medicinal cannabis producer

  • Utilizes a cost-effective, year-round indoor and outdoor cultivation process for high-quality, competitively priced cannabis flower

  • Boasts a 12-acre footprint, yielding up to 41 tonnes of medicinal cannabis annually with 24 harvests, ensuring a steady, uninterrupted supply

  • Very low, industry-leading cost of production beats out black market prices

  • Exclusive genetics and a robust management team contribute to ongoing success and staying current with market trends through an ongoing and extensive breeding program

  • Company has established relationships with exporters who have existing supply pathways into the UK and EU, with signed off-take agreements

  • Company is on track to become one of the first and largest organic, outdoor-hybrid medicinal cannabis grow facilities in Australia

  • Outdoor cultivation enhances terpene and cannabinoid profiles, resulting in a superior product experience for patients

  • Strategic growth plans include potential scaling to 100 acres to capture more significant market share

  • Company has defined clear commercial pathways for its flower and biomass derivatives such as fresh frozen live rosin, with prices for the finished products providing a strong and sustainable margin

  • Currently seeking strategic investment to fully activate their path to production and market entry

18093149037

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal
bottom of page